Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Praxis Precision Medicines (PRAX) Net Cash Flow (2022 - 2025)

Historic Net Cash Flow for Praxis Precision Medicines (PRAX) over the last 4 years, with Q3 2025 value amounting to -$7.9 million.

  • Praxis Precision Medicines' Net Cash Flow fell 13356.31% to -$7.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$19.1 million, marking a year-over-year decrease of 12829.78%. This contributed to the annual value of $134.1 million for FY2024, which is 58108.71% up from last year.
  • Latest data reveals that Praxis Precision Medicines reported Net Cash Flow of -$7.9 million as of Q3 2025, which was down 13356.31% from -$8.2 million recorded in Q2 2025.
  • Praxis Precision Medicines' Net Cash Flow's 5-year high stood at $70.7 million during Q1 2024, with a 5-year trough of -$61.4 million in Q1 2022.
  • Moreover, its 4-year median value for Net Cash Flow was -$6.8 million (2024), whereas its average is $681533.3.
  • Its Net Cash Flow has fluctuated over the past 5 years, first tumbled by 229818.18% in 2023, then soared by 33617.39% in 2024.
  • Over the past 4 years, Praxis Precision Medicines' Net Cash Flow (Quarter) stood at -$825000.0 in 2022, then plummeted by 2298.18% to -$19.8 million in 2023, then soared by 336.17% to $46.7 million in 2024, then tumbled by 116.88% to -$7.9 million in 2025.
  • Its Net Cash Flow stands at -$7.9 million for Q3 2025, versus -$8.2 million for Q2 2025 and -$49.8 million for Q1 2025.